Additional Reading
White Lesions
Appleton SS. Candidiasis: pathogenesis, clinical characteristics, and treatment. J Calif Dent Assoc 2000;28:942–8.
Axell T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18–21, 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1996;25:49–54.
Batsakis JG, Suarez P, el-Naggar AK. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol 1999;35:354–9.
Carbone M, Conrotto D, Carrozzo M, et al. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 1999;5:44–9.
Cruchley AT, Williams DM, Niedobiek G, Young LS. Epstein-Barr virus. Biology and disease. Oral Dis 1997;3 Suppl 1:S156–63.
Dufresne RG Jr, Curlin MU. Actinic cheilitis. A treatment review. Dermatol Surg 1997;23:15–21.
Fettig A, Pogrel MA, Silverman S Jr, et al. Proliferative verracous leukoplakia of the gingiva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:723–30.
Grbic JT, Lamster IB. Oral manifestations of HIV infection. AIDS Patient Care STDS 1997;11:18–24.
Guccion JG, Redman RS. Oral hairy leukoplakia: an ultrastructual study and review of the literature. Ultrastruc Pathol 1999;23:181–7.
Martin GC, Brown JP, Eifler CW, Houston GD. Oral leukoplakia status six weeks after cessation of smokeless tobacco use. J Am Dent Assoc 1999;130:945–54.
McCreary CE, McCartan BE. Clinical management of oral lichen planus. Br J Oral Maxillofac Surg 1999;37:338–43.
Mirbod SM, Ahing SI. Tobacco-associated lesions of the oral cavity: Part I. Nonmalignant lesions. J Can Dent Assoc 2000;66:252–6.
White Lesions
Appleton SS. Candidiasis: pathogenesis, clinical characteristics, and treatment. J Calif Dent Assoc 2000;28:942–8.
Axell T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobacco-related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18–21, 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1996;25:49–54.
Batsakis JG, Suarez P, el-Naggar AK. Proliferative verrucous leukoplakia and its related lesions. Oral Oncol 1999;35:354–9.
Carbone M, Conrotto D, Carrozzo M, et al. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 1999;5:44–9.
Cruchley AT, Williams DM, Niedobiek G, Young LS. Epstein-Barr virus. Biology and disease. Oral Dis 1997;3 Suppl 1:S156–63.
Dufresne RG Jr, Curlin MU. Actinic cheilitis. A treatment review. Dermatol Surg 1997;23:15–21.
Fettig A, Pogrel MA, Silverman S Jr, et al. Proliferative verracous leukoplakia of the gingiva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:723–30.
Grbic JT, Lamster IB. Oral manifestations of HIV infection. AIDS Patient Care STDS 1997;11:18–24.
Guccion JG, Redman RS. Oral hairy leukoplakia: an ultrastructual study and review of the literature. Ultrastruc Pathol 1999;23:181–7.
Martin GC, Brown JP, Eifler CW, Houston GD. Oral leukoplakia status six weeks after cessation of smokeless tobacco use. J Am Dent Assoc 1999;130:945–54.
McCreary CE, McCartan BE. Clinical management of oral lichen planus. Br J Oral Maxillofac Surg 1999;37:338–43.
Mirbod SM, Ahing SI. Tobacco-associated lesions of the oral cavity: Part I. Nonmalignant lesions. J Can Dent Assoc 2000;66:252–6.
Reichart PA, Samaranayake LP, Philipsen HP. Pathology and clinical correlates in oral candidiasis and its variants: a review. Oral Dis 2000; 6:85–91.
Rogers RS III, Bekic M. Diseases of the lips. Semin Cutan Med Surg 1997;16:328–36.
Rugg EL, Magee GJ, Wilson NJ, et al. Identification of two novel mutations in keratin 13 as the cause of white sponge naevus. Oral Dis 1999;5:321–4.
Rugg EL, McLean WH, Allison WE. A mutation in mucosal keratin K4 is associated with oral white sponge nevus. Nat Genet 1995;11:450–2.
Saito T, Sugiura C, Hirai A, et al. High malignant transformation rate of widespread multiple oral leukoplakias. Oral Dis 1999;5:15–9.
Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Dis 1999;5:206–9.
Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med 1995;6:147–60. Walsh PM, Epstein JB. The oral effects of smokeless tobacco. J Can Dent
Assoc 2000;66:22–5. Zhang I, Cheung KJ Jr, Lam WL, et al. Increased genetic damage in oral
leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer 2001;91:2148–55.
Rogers RS III, Bekic M. Diseases of the lips. Semin Cutan Med Surg 1997;16:328–36.
Rugg EL, Magee GJ, Wilson NJ, et al. Identification of two novel mutations in keratin 13 as the cause of white sponge naevus. Oral Dis 1999;5:321–4.
Rugg EL, McLean WH, Allison WE. A mutation in mucosal keratin K4 is associated with oral white sponge nevus. Nat Genet 1995;11:450–2.
Saito T, Sugiura C, Hirai A, et al. High malignant transformation rate of widespread multiple oral leukoplakias. Oral Dis 1999;5:15–9.
Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Dis 1999;5:206–9.
Sciubba JJ. Oral leukoplakia. Crit Rev Oral Biol Med 1995;6:147–60. Walsh PM, Epstein JB. The oral effects of smokeless tobacco. J Can Dent
Assoc 2000;66:22–5. Zhang I, Cheung KJ Jr, Lam WL, et al. Increased genetic damage in oral
leukoplakia from high risk sites: potential impact on staging and clinical management. Cancer 2001;91:2148–55.